Human myeloid progenitor cells temporarily express HLA class II molecules during the differentiation pathway to granulocytes and macrophages. The significance of major histocompatibility complex ( " 3 
HE HLA CLASS I1 MOLECULES are a family of transmembrane heterodimeric glycoproteins that play a central role in the cellular immune response.' HLA class I1 molecules are expressed on B cells, activated T cells, macrophages, dendritic cells, and certain hematopoietic progenitor cells.2 HLA class I1 molecules expressed by mature antigenpresenting cells (APCs) provide a stable, receptor-like environment for the binding of peptides derived from self-and nonself-protein^.^ These peptides, bound on the surface of APCs, are presented to CD4 T-helper lymphocytes for surveillance and recognition. As hematopoietic progenitor cells pass through the myeloblast or colony-forming unit-granulocyte-macrophage stage, they temporarily express HLA class I1 molecules. After this stage, expression of HLA class I1 molecules is lost and regained later by mature monocytemacrophage^.^ The functional significance of the HLA class I1 molecules expressed by progenitor cells is unknown but may be related to shaping of the T-cell repertoire or to the presentation of foreign antigen. KG-1 is a cell line that shows many of the phenotypic characteristics of the colony-forming unit-granulocyte-macrophage progenitor cells, including the expression of HLA class I1 molecules and invariant chain.
KG-l cells were derived from a patient with acute myelogenous le~kemia.~ The line is morphologically heterogeneous, containing cells that stain predominantly as myeloblasts and, to a lesser extent, as promyelocytes, myelocytes, granulo-cytes, macrophages, and eosinophils. The presence of eosinophil-like cells, as well as granulocyte-and macrophage-like cells, suggests that this line was derived from an oligopotent myeloid progenitor cell. Within the KG-l population, less than 5% of the cells show histochemical or functional characteristics of mature myeloid cells (ie, Fc receptor expression, myeloperoxidase or phagocytosis of opsonized Candida al-KG-l cells stimulate T-cell reactivity in mixed lymphocyte cultures, showing that they express the necessary costimulatory molecules (eg, CD1 8, CD29, CD59) required for T-helper cell activation."* As a first step of inquiry into the functional significance of the Ia molecules expressed by progenitor cells, we have partially characterized the profile of self-peptides bound to the HLA class I1 molecules expressed by KG-] leukemic myeloblasts. From the pool of HLA class 11-bound peptides, we obtained the sequences of 21 high copy number peptides. Alignment of these self-peptide sequences showed the allelespecific motifs of the HLA-DR 1101 and 1401 molecule. Searches of the sequence data bases showed seven matches to known protein precursors, all of which corresponded to intracellular proteins. No matches to exogenous or transmembrane proteins were found. The fact that predominant self-peptides of KG-l cells differ in origin from those bound to the HLA class I1 molecules of mature APCs studied so far suggests that exogenous antigen processing is not operational in these cells. The absence of self-peptides derived from the processing of exogenous and membrane-associated precursors, and the phenotypic immaturity of KG-l cells, together, may indicate that the classical pathway of major histocompatibility complex (MHC) class I1 antigen processing is acquired only at later stages of myeloid differentiation.
MHC BOUND PEPTIDES IN NONPROFESSIONAL APC 5105
sity, New York, NY) and has been described elsewhere! The lymphoblastoid B-cell line (LBCL), BM21, (-3) was distributed by the Tenth International HLA Workshop. The above cells were maintained in RPMI 1640 medium supplemented with 10% (voVvo1) fetal calf serum (FCS), 1% (voUvol) glutamine, and 0.5% (voUvol) gentamycin. Bulk cultures of KG-l cells were established in roller bottles for the isolation of HLA-DR bound peptides. The BrCaNi cell line (erbB2+, estrogen receptor+), was established from a pleural effusion of a patient with breast cancer and was grown in Dulbecco's modified Eagle's medium with 10% FCS. 5 mg/L bovine insulin, and 10 mg/L hydrocortisone. For induction of HLA-DR expression, BrCaNi cells were cultured in complete Dulbecco's modified Eagle's medium supplemented with 500 U/mL of human recombinant yinterferon (y-IFN; Boerhringer Mannheim, Indianapolis, IN). Hybridoma cell lines were cultured in RPMI 1640 medium supplemented with IgG-free FCS (all FCS and all solutions from GIBCO, Grand Island, NY). Normal human hematopoietic progenitor cell populations were obtained from Ficoll-Hypaque-purified (Sigma CO, St Louis, MO) marrow aspirates or from leukopheresis products after routine CD34+ cell enumeration.
Antibodies (Abs). The murine hybridoma L243 producing the anti-HLA-DR Ab recognizing the nonpolymorphic a 1 and the 81, 83, and 85 chains of mature HLA class I1 molecules" and the murine hybridoma producing the anti-HLA-A,B,C Ab, W632 were obtained from the ATCC. The N-terminus-directed anti-invariant chain Ab (PIN-l) and the anti-class 11-associated invariant chain peptide (anti-CLIP) Ab (cerCLIP-l) were a generous gift of Dr P.
Cresswell (Yale University School of Medicine, New Haven, CT) and have been previously described."."
ImmunoJluorescent Jlow cytometry. The cell surface expression of HLA-DR, HLA-A,B,C, CLIP, and CD34 were determined by direct or indirect immunofluorescence as previously describedI4 using a Becton Dickinson (Mountain View, CA) FACScan instrument. The phycoerythrin-labeled anti-CD34 monoclonal Ab (MoAb), isotype control, and fluorescein isothiocyanate-labeled antimouse Ig were obtained from Becton Dickinson. The flow cytometric identification and enumeration of CD34+ normal progenitor cells was performed as previously described.I5
ImmunoafJinity purification of class II molecules and elution of bound peptides. KG-l cells were cultured to a final yield of 2 X cells. The immunoaffinity purification of HLA-DR molecules and the elution of bound peptides were performed as previously described? An aliquot of the purified HLA-DR protein was analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and silver staining and was judged to be greater than 90% pure. The final yield of HLA class I1 molecules was 1,020 pg, as determined by the bicinchonic acid (BCA) assay kit (Pierce, Rockford, IL).
Radiolabeling. Cells were preincubated in methionine-free RPMI, supplemented with L-glutamine, 2% dialyzed FCS, and 0.5% gentamycin for 1 hour at 37°C. Cells were then labeled for 30 minutes with 500 pCi [?S] methionine Trans-Label (ICN, K&K Laboratories Inc, Plainview, NJ). After the labeling period, cells were chased for varying periods of time in complete RPMI supplemented with a 10-fold excess of cold methionine (Sigma).
Analysis of HLA-DR and invariant chain protein expression. Immunoprecipitation of HLA-DR and invariant chain proteins from [3sS] metabolically labeled cell lysates was performed as previously described."
Catabolism of cell surface HLA-DR molecules. The cell surface proteins of live cells were labeled in 10 mmoVL NHS-biotin (Pierce, Rockford, IL) in phosphate-buffered saline, pH 9.0, for 5 minutes at room temperature. After the labeling reaction, the cells were washed twice in RPMI 1 6 4 0 media to remove cellular debris and unreacted N-hydroxylsuccinamide (NHS)-biotin. Labeled cells were returned to complete medium and incubated for varying periods of time. At the indicated time, duplicate aliquots containing 6 X lo6 viable cells were removed and immunoprecipitated with the anti-HLA-DR MoAb L243 conjugated to Sepharose 4B (20 pL) as previously described? In parallel control experiments, lysates from different amounts of labeled HLA-DR+ cells and unlabeled cells were immunoprecipitated with MoAb L243. Lysate from labeled cells was also immunoprecipitated with a control nonimmune isotype control Ab. After the last immunoprecipitation washing step, the immune complexes were incubated for 15 minutes with a streptavidin and alkaline phosphatasehiotin detection reagent (ABC kit; Pierce). The complexes were washed twice in phosphate-buffered saline and transferred to a flat-bottomed 96-well tray, and alkaline phosphatase substrate solution was added to the complexes. The complexes were incubated at room temperature and serial measurements of the absorbance at 415 nm of the supernatants were taken. From the serial absorbance measurements, the rate of substrate formation (as change in optical density per 30-minute interval) was determined. This rate was proportional to the relative amounts of immunocomplexed HLA-DR molecules and the amount of labeled HLA-DR molecules on the cell surface.
Northern analysis of invariant chain expression. Total RNA was extracted from cells as previously described.16 Total RNA from each sample (30 Mg) was loaded on 1.6% agarose/formaldehyde gel. Separation and transfer of RNA to nylon membranes was performed using standard methods.I7 The plasmid (p33-143) containing the cDNA coding for p33/p35 isoform of invariant chain (a kind gift of Dr E.O. Long, National Institutes of Health, Rockville, MD) and a control &actin cDNA were used as probes. The DNA labeling was performed using standard methods.17 Hybridization was performed at 65°C using the Rapid Hybridization Mix from Amersham (Arlington Heights, IL) following the manufacturer's recommendations. Membranes were first probed with p33-143, exposed, rehybridized with the 8-actin probe, and exposed again. The autoradiograms were analyzed by densitometry.
High-performance liquid chromatography (HPLC) purijication and sequencing of eluted peptides. The separation of MHC-bound peptides, eluted from the HLA-DR molecules of KG-l cells, was performed as previously From the absorbance trace at 215 nm of the eluate, the single fractions containing absorbance peaks were selected for microsequencing by N-terminal Edman degradation using a Hewlett-Packard (Palo Alto, Ca) GlOOOA protein sequencer. All fractions containing materia1 showing an absorbance at 215 nm were sequenced. Single-fraction sequencing regularly yields cycles containing multiple F"I-amino acids and mixed sequences. For the assignment of major and minor sequences from these data, we used previously published Only major sequences and their calculated initial yields appear in Table 1 . The cumulative yield of predominant peptides, ie, the major sequences, was approximately 800 pmol. The cumulative yield of major and minor sequence peptides was estimated to be approximately 2,400 pmol (15% of total HLA class II-bound peptides; data not shown).
In a control experiment, 2 mL of the complete growth medium was separated into high and low molecular weight fractions by ultrafiltration. The low molecular fraction was lyophilized to dryness and reconstituted in dilute trifluoroacetic acid (TFA). The low molecular fraction of the complete growth medium was loaded onto the C18 sequencing column, washed with 5% acetonitrile/O.l% TFA, and sequenced as a pool. Two major sequence peptides (DPID-PEAAYKR and ITHKPVIGHR, at concentrations of less than 350 ng/mL) were found. None of these peptides present in the culture medium were found to be associated with the HLA-DR molecules expressed by KG-l cells.
HLA class I1 typing. KG-l cells were typed by conventional serology methods for HLA-A and -B antigens. HLA-DR alleles were characterized by genomic typing of in vitro amplified DNA with For personal use only. on September 24, 2017. by guest www.bloodjournal.org From 
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47
Histone H4 (31-45) 52
100%
Histone H4 (30-46) 53
Histone H4 (29-46) 54
Pleckstrin (164-179) 66
70
100% Actin (207-217) 70
Glyceraldehyde-3-phosphate, dehydrogenase (8-19) 71 
RESULTS
Self-peptides bound to HLA-DR of KG-l cells. From the pool of HLA-DR 11-and 14-bound peptides, separated by reverse-phase HPLC (Fig l) , we obtained clear sequences of 21 high copy number peptides. Searches of the SwissProt data base for amino acid sequence homology showed seven matches to known protein precursors ( Table 1 ). The HLA class
II-
bound self-peptides characterized from fractions 47, 52, and 53 matched to Histone H4. These three peptides formed a nested set with a combined yield of 136 pm01 (Table 2) . Two peptides were derived from actin (fractions 59 and 69). These peptides were also nested set isoforms with combined yield of 148 pmol (Table 2) . Two additional peptides were characterized: one peptide (fraction 65), matched at 14 of 15 residues to Plecskstrin with a yield of 24 pm01 and a second peptide derived from glyceraldehyde 3-phosphate dehydrogenase (fraction 70) with a yield of 57 pmol. Among all the HLA-DR 11-and DR 14-bound peptides characterized, there were no matches or partial matches to HLA-related proteins or the invariant chain. Thus, the intracellular origins of the major HLA-DR-bound self-peptides of KG-l cells are distinct from the origins of self-peptides characterized in other mature APCs studied to date.22-26
Analysis of HLA and CLIP expression. The absence of MHC-related peptides among the major self-peptides presented by KG-l cells suggested that there might be some abnormality in the expression or turnover of HLA molecules themselves. Alternatively, because assembly, transport, and normal peptide loading of HLA-DR molecules is dependent on the expression of the invariant chain molec~le,~' it was possible that some alteration in the expression of the invariant chain might underlie the apparent difference in antigen processing observed in KG-l cells.
To distinguish between the hypotheses, immunofluorescence flow cytometric measurements were obtained to determine the expression of HLA-DR and HLA-A,B,C in KG-l cells, in a hemi-allogeneic LBCL (BM21), in the mature monocyte-like cell line THP-1, in KG-1 a (the less differentiated variant of KG-l), and in normal CD34+, HLA-DR' progenitor cells obtained from marrow or peripheral blood. Peptide fragments resulting from the proteolytic processing of invariant chain (CLIP) comprise part of the complement of major self-peptides bound to many HLA-DR molecules expressed by LBCLS.'~ In these studies, we also obtained a relative measure of the occupancy of HLA-DR molecules by these peptides using an anti-CLIP Ab. The anti-CLIP Ab detects HLA-DR-bound peptide fragments (encompassed by residues 85-105) that derive from the invariant chain protein.28 These data are summarized in Fig 2. These studies showed that HLA-A,B,C expression was highest among the KG-la cell population, followed by approximately equal expression in KG-l, the BM21 LBCL, and THP-1 cells. The lowest level of HLA class I expression was observed within the normal CD34' stem cell population. The pattern of HLA-DR expression was different from that of HLA-A,B,C. HLA-DR expression was extremely weak on KG-la cells, intermediate in the LBCL and THP-l cells, and highest on KG-l and normal CD34' cells. CLIP expression in each of the cell populations showed a broad distribution but was highest in THP-1 cells, followed by the LBCL and KG-l cells, and was lowest among CD34+ cells and KG-la cells.
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To determine the relative occupancy of HLA-DR by CLIP among the cell lines, the value of mean channel fluorescence (MCF) of CLIP expression was divided by the value of MCF of HLA-DR expression for each cell population studied ( Table 3) . Whereas the MCF values for each cell population were not equal to the actual number of CLIP or HLA-DR molecules per cell, the ratio of the MCF of CLIP to the MCF of HLA-DR showed significant differences among the populations studied. The THP-1 cell line had the highest value for CLIP-to-HLA-DR MCF ratio. The HLA-DR 11+ LBCL had a CLIP-to-HLA-DR MCF ratio of 0.89. KG-l cells and CD34+ had similar CLIP-to-HLA-DR MCF ratios (0.06). These values were approximately 15-fold lower than the MCF ratios observed for THP-1 and the BM21 LBCLs.
The CLIP-to-HLA-DR MCF ratios appeared to distinguish professional APC (ie, LBCLs) from the nonprofessional APC KG-l cells. As an additional confirmation of the observation, we extended this analysis to a breast carcinoma cell line. The BrCaNi cell line (erbB2+, estrogen receptor+), was analyzed for HLA-DR and CLIP expression after 3 days of culture in the presence and absence of 500 UlmL The MCF values and their ratios are not directly comparable with the molar yields.
recombinant -y-IFN. HLA-DR expression was detectable
only after y-IFN treatment and only in 30% of the total BrCaNi cell population. The ratio of CLIP-to-HLA-DR in the class 11' cells was 0.07 (Table 3) . Nonprofessional APCs, ie, KG-l cells, CD34+ progenitor cells, and HLA-DR' breast carcinoma cells, have a low CLIP-to-HLA-DR ratio, possibly the result of strong competition by endogenous peptides for MHC class I1 occupancy. 
HLA-DR
" p:
liized by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and autoradiography (Fig 3) . KG-l cells expressed significantly more HLA-DR molecules than did THP-I cells. By 36 hours, more than half the original signals from labeled HLA-DR molecules were lost in the KG-l and THP-I cell lines, suggesting that HLA-DR proteins have similar halflives in these two lines. The (Y and b chains of HLA-DR were detectable in KG-l a cells only after prolonged autoradiographic exposure of the labeled protein. An antiserum directed against the N terminus of the invariant chain (PIN-1) was used to compare the expression of invariant chain protein in KG-l, THP-1, and KG-1 a cells. The level of HLA-DR and invariant chain proteins were significantly lower in THP-I cells compared with that in KG-l cells. For this reason, IO-fold more THP-I and KG-la cells (yielding IO-fold greater trichloroacetic acid [TCAI-precipitable counts) than KG-l cells were used for immunoprecipitation. From I X IO" KG-l cells, a band of an apparent molecular weight of slightly greater than 35 kD was obtained. Using I X IO' THP-I cells, a band (doublet) corresponding to the 33-to 35-kD isoform of the invariant chain was observed. similar to the pattern observed in other HLA class 11' professional APCs (Fig 3) .?') Invariant chain protein could be detected in KG-la cells, but only after prolonged autoradiographic exposure (data not shown).
Northern analysis sf invariant chain. The expression of invariant chain mRNA in KG-l. KG-I a. BM2 1 -LBCL. THP-1. and BrCaNi cells was analyzed using a probe specific for the p33/35 isoform of the invariant chain. Invariant chainspecific mRNA was detected in all five cell lines tested. The relative level of invariant chain message, using p actin as a control. was lowest in KG-la cells. followed by BrCaNi cells, was intermediate in KG-l cells. was highest in THP-1 and the LBCL (data not shown), and generally paralleled the immunofluorescence results.
DISCUSSION
The functional significance of the HLA class I1 molecules expressed on the surface of hematopoietic progenitor cells is unknown. In this study. we analyzed the profile and origins of the major self-peptides bound to the HLA class I1 molecules expressed by KG-l cells as a means to determine whether immature myeloid cells show antigen-processing mechanisms similar to those of other mature HLA class 11-APCs. In mature APCs, the processing of potential protein antigens occurs in topographically distinct compartments specialized for the delivery of peptide to either HLA class I or class II molecules. Proteins synthesized and processed within the cytosol are normally presented by HLA class I molecules. whereas exogenous proteins. internalized and degraded in vesicular spaces. are presented by MHC class II molecules.
HARRIS ET AL
The sequence analysis of peptides bound to the HLA-DR molecules of KG-l cells showed that the predominant selfpeptides originated from intracellular, rather than exogenous or transmembrane, proteins. In the studies described above, we obtained sequences of 21 high copy number peptides, 6 of which showed 100% homology to the intracellular proteins histone H4, actin, or glyceraldhyde-3-phosphate dehydrogenase. A seventh peptide was 93% homologous to the protein kinase C substrate pleckstrin (residues 164-179). This peptide contained a valine for serine substitution at position 168, possibly the result of a mutation.
The set of KG-l self-peptides could be aligned by sequence motifs into two distinct sets. One set contained peptides carrying an i + 5 motif, corresponding to the previously published allele-specific motif of HLA-DR 1 10.22," The second set contained peptides with an i + 7 pattern, presumably bound to DR 1401 molecules ( Table 2 ). In this latter set, the major preferences for the first anchor residue (at i) were an aliphatic leucine or isoleucine residue. The C-terminal anchor, spaced seven residues away, showed clear preference for positively charged arginine or lysine residues. Comparison of the nucleotide sequences of HLA-DR 1401 and DR 1501 suggests that they have identical amino acids lining the A pocket (ie, valine at position 86, phenylalanine at position 89, threonine at position 90, and aspartate at position 52). On the basis of the crystal structure of HLA-DR 1 molecule,32 the A pocket is involved in binding of the first anchor residue. The allele specific motif for HLA-DR 1501 has been determined by similar methods and shows a preference for I and L at position i.24 The assignment of the motif for HLA-DR 1401 is compatible with this structural data.
The combined yield of the intracellular self-peptides accounted for 45% of the total mass of the peptides characterized. None of the HLA-DR 11-and DR 14-bound peptides characterized showed matches or partial matches to HLArelated proteins, invariant chain proteins, or other transmembrane proteins. The presence of intracellular proteins and the absence of MHC-related proteins together suggest that the antigen-processing mechanisms that yield the self-peptides bound to LBCLs and splenocytes are distinct from those present in KG-l cells.22~2h In human B-cell lines, the predominant source of naturally processed MHC-bound peptides is the MHC molecules themselves. MHC-related proteins supply 75% to 95% of the self-peptides bound to HLA-DR molecules, whereas other membrane-associated molecules and exogenous proteins contribute to the self-peptide pool at a lower frequency.22-26 Transmembrane cell surface receptors provide HLA-DR-bound peptides via the endocytic route associated with normal catabolism of cell surface protein^.'^ Oligopeptides, resulting from their endocytic and lysosomal degradation, are probably transferred to or meet with newly synthesized HLA class I1 molecules in a late endosomal compartment (class 11-containing vesicles) in which conditions for the interaction between HLA-DWinvariant chain complexes, HLA-DM, and peptides may be idea1. '2,28,"4,35 Because peptides derived from MHC molecules were not found in the pool of KG-1 -bound self-peptides, we determined whether there were any abnormalities in the metabolism of HLA molecules expressed by these cells. Comparison of the expression, synthesis, and turnover rates of HLA class 11 molecules in KG-l cells to two other cell lines, a DR 1 1 + LBCL and THP-1 monocytes, showed that the metabolism of HLA-DR molecules was not significantly different in KG-1 cells from the other cells studied in this report and apparently could not account for absence of MHC-related selfpeptides in the antigen-binding groove.
After the assembly of HLA-DR cy and / 3 heterodimers in the endoplasmic reticulum, class I1 molecules closely associate with the invariant chain (Ii)." These aPIi complexes contain no detectable exogenous peptides" and are directed to an endocytic compartment via a sorting sequence contained in the cytoplasmic N terminal domain of Ii. Within this endocytic compartment, the Ii chain is degraded and the c @ dimers are loaded with new peptides in an HLA-DMdependent manner." This process is not 100% efficient, and peptide fragments of invariant chain often remain within the antigen-binding groove. Thus, CLIPs often significantly contribute to the repertoire of self-peptides bound to HLA-DR molecules.'6 CLIPs are presented by HLA-DR 1101' splenocytes,26 and CLIPs have been eluted from DR 11-transfected T2 antigen-processing mutant cell^.'^ Because CLIP presentation by HLA-DR is a characteristic of antigen processing in normal B-cell lines and LBCLs, we determined the occupancy of HLA-DR molecules by CLIP in KG-l cells, THP-1 monocytes, CD34' HLA-DR' normal hematopoietic progenitor cells, and a y-IFN-induced breast carcinoma cell line using a DR 11 homozygous BM21-LBCL as a positive control. In these studies, we found that the "professional" APCs such as BM21-LBCL and THP-l monocytes had significantly higher CLIP occupancy of HLA-DR than did the nonprofessional APCs, ie, the KG-l cells, HLA-DR' stem cells, and breast carcinoma cells. This observation correlated with our failure to find CLIP among the major self-peptides bound to the HLA-DR molecules of KG-1 cells and provides additional evidence that KG-1 cells and normal CD34+ cells are different from LBCLs in their disposition of invariant chain/HLA-DR complexes.
Comparative analysis of invariant chain mRNA levels showed no qualitative differences among the cells included in these studies. At the protein level, the KG-l invariant chain has a slightly higher molecular weight relative to those of the invariant chain proteins present in THP-1 cells, perhaps the result of altered glycosylation. Further study will be required to determine whether this alteration in invariant chain structure is responsible for the observed pattern of self-peptides bound to HLA-DR in KG-l cells.
The phenomenon of MHC class I1 presentation of antigens admitted by an endogenous pathway has been previously documented in LBCLs and other APCs.22~24~25~38~40 Endogenous peptides contribute less than 5% of the total mass of HLA-DR-bound self-peptides presented by B-cell lines. The relative contribution of endogenous versus exogenous protein-derived peptides has not been established in other APCs. Cytosolic proteins that supply HLA-DR-bound selfpeptides may enter the endocytic route via the autophagic vacuole4' or use a transport associated protein-dependent proce~s.~" Electron microscopic studies of over 50 thin sections did not show a significant presence of autophagic vacuFor personal use only. on September 24, 2017. by guest www.bloodjournal.org From oles in KG-l cells (data not shown). The data presented in this report suggest that antigen-processing pathways, different from those described for mature APCs, are in operation in KG-l cells. The basis of this difference remains unknown, yet possible reasons may include the absence of targeting molecules that direct endocytic vesicles to the class II-containing vesicles. The expression of such targeting molecules may be acquired at later stages of myeloid development. The data are also consistent with the existence "cross-talk'' between the exogenous and endogenous pathways of antigen processing. This phenomenon has been described in other cells of myeloid lineage. For example, in the phenotypically mature U937 monocyte cell line, self-peptides derived from exogenous serum proteins are presented by HLA class I molecules."
Although it is possible that the unique MHC class I1 antigen presentation characteristic of KG-l cells is a result of malignant transformation, the data presented in this report suggest that at least some characteristics of antigen presentation are common to KG-l and normal CD34+ stem cells. Additional study will be required to determine whether normal progenitor cells and KG-l cells indeed share the property of MHC class I1 presentation of intracellular protein-derived peptides. At this point, however, we can speculate on the function that HLA class I1 molecules may have at this early stage of development. First, because these progenitors will proliferate and disseminate into the periphery, the presentation of endogenous viral protein-derived peptides by HLA class I1 molecules for CD4+ T-cell surveillance seems particularly important. Second, the presentation of endogenous self-protein-derived peptides by HLA class II+ hematopoietic progenitors may play a role in defining the adult CD4+ T-cell repertoire after involution of the thymus. This hypothesis is supported by experiments showing that MHC class IC hematopietic cells direct positive selection and maturation of CD4/CD8' T cells into CD8+ T cells:'
